vs
Side-by-side financial comparison of Broadstone Net Lease, Inc. (BNL) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Broadstone Net Lease, Inc. is the larger business by last-quarter revenue ($121.4M vs $75.5M, roughly 1.6× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 11.7%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 7.1%).
Broadstone Net Lease, Inc. is a real estate investment trust (REIT) that acquires, owns, and manages a diversified portfolio of single-tenant commercial real estate assets across the United States. Its portfolio covers key segments including industrial facilities, healthcare properties, retail locations, and office spaces, all leased to tenants under long-term net lease agreements.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
BNL vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $121.4M | $75.5M |
| Net Profit | $46.4M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 52.2% | 22.7% |
| Net Margin | 38.2% | — |
| Revenue YoY | 11.7% | 27.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.24 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $121.4M | — | ||
| Q4 25 | $118.3M | $75.5M | ||
| Q3 25 | $114.2M | $54.5M | ||
| Q2 25 | $113.0M | $52.4M | ||
| Q1 25 | $108.7M | $46.0M | ||
| Q4 24 | $112.1M | $59.1M | ||
| Q3 24 | $108.4M | $80.5M | ||
| Q2 24 | $105.9M | $47.1M |
| Q1 26 | $46.4M | — | ||
| Q4 25 | $33.1M | — | ||
| Q3 25 | $26.5M | $8.8M | ||
| Q2 25 | $20.2M | $5.9M | ||
| Q1 25 | $16.7M | $3.0M | ||
| Q4 24 | $26.4M | — | ||
| Q3 24 | $35.6M | $20.3M | ||
| Q2 24 | $35.3M | $-4.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
| Q1 26 | 52.2% | — | ||
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% |
| Q1 26 | 38.2% | — | ||
| Q4 25 | 28.0% | — | ||
| Q3 25 | 23.2% | 16.2% | ||
| Q2 25 | 17.8% | 11.2% | ||
| Q1 25 | 15.4% | 6.5% | ||
| Q4 24 | 23.5% | — | ||
| Q3 24 | 32.8% | 25.2% | ||
| Q2 24 | 33.4% | -9.6% |
| Q1 26 | $0.24 | — | ||
| Q4 25 | $0.17 | $0.26 | ||
| Q3 25 | $0.14 | $0.17 | ||
| Q2 25 | $0.10 | $0.12 | ||
| Q1 25 | $0.09 | $0.06 | ||
| Q4 24 | $0.13 | $0.40 | ||
| Q3 24 | $0.19 | $0.41 | ||
| Q2 24 | $0.19 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.3M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $3.0B | $130.3M |
| Total Assets | $5.8B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $20.3M | — | ||
| Q4 25 | $30.5M | $97.5M | ||
| Q3 25 | $82.0M | $94.4M | ||
| Q2 25 | $20.8M | $96.0M | ||
| Q1 25 | $9.6M | $93.2M | ||
| Q4 24 | $14.8M | $101.0M | ||
| Q3 24 | $9.0M | $96.7M | ||
| Q2 24 | $18.3M | $96.8M |
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | $22.7M | ||
| Q3 25 | $2.4B | $34.0M | ||
| Q2 25 | $2.1B | $45.3M | ||
| Q1 25 | $2.0B | $56.7M | ||
| Q4 24 | $1.9B | $68.0M | ||
| Q3 24 | $2.0B | $79.3M | ||
| Q2 24 | $1.9B | $90.7M |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $2.9B | $130.3M | ||
| Q3 25 | $2.9B | $115.3M | ||
| Q2 25 | $2.9B | $104.7M | ||
| Q1 25 | $2.9B | $97.1M | ||
| Q4 24 | $3.0B | $92.1M | ||
| Q3 24 | $3.0B | $71.1M | ||
| Q2 24 | $3.1B | $48.5M |
| Q1 26 | $5.8B | — | ||
| Q4 25 | $5.7B | $216.3M | ||
| Q3 25 | $5.5B | $202.9M | ||
| Q2 25 | $5.3B | $194.9M | ||
| Q1 25 | $5.2B | $196.2M | ||
| Q4 24 | $5.2B | $213.3M | ||
| Q3 24 | $5.3B | $220.7M | ||
| Q2 24 | $5.3B | $205.0M |
| Q1 26 | — | — | ||
| Q4 25 | 0.87× | 0.17× | ||
| Q3 25 | 0.82× | 0.30× | ||
| Q2 25 | 0.73× | 0.43× | ||
| Q1 25 | 0.68× | 0.58× | ||
| Q4 24 | 0.64× | 0.74× | ||
| Q3 24 | 0.65× | 1.12× | ||
| Q2 24 | 0.62× | 1.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $299.5M | $14.4M | ||
| Q3 25 | $64.2M | $9.7M | ||
| Q2 25 | $79.3M | $14.1M | ||
| Q1 25 | $71.5M | $3.6M | ||
| Q4 24 | $276.3M | $15.6M | ||
| Q3 24 | $67.3M | $11.0M | ||
| Q2 24 | $74.2M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | $269.8M | $14.4M | ||
| Q3 25 | $58.0M | $9.7M | ||
| Q2 25 | $76.7M | $14.1M | ||
| Q1 25 | $57.1M | $3.6M | ||
| Q4 24 | $259.5M | $15.6M | ||
| Q3 24 | $60.3M | $11.0M | ||
| Q2 24 | $74.0M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | 228.1% | 19.1% | ||
| Q3 25 | 50.8% | 17.7% | ||
| Q2 25 | 67.9% | 26.8% | ||
| Q1 25 | 52.5% | 7.7% | ||
| Q4 24 | 231.4% | 26.4% | ||
| Q3 24 | 55.6% | 13.7% | ||
| Q2 24 | 69.9% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 25.1% | 0.0% | ||
| Q3 25 | 5.4% | 0.0% | ||
| Q2 25 | 2.3% | 0.0% | ||
| Q1 25 | 13.2% | 0.1% | ||
| Q4 24 | 15.0% | 0.0% | ||
| Q3 24 | 6.5% | 0.0% | ||
| Q2 24 | 0.2% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 9.04× | — | ||
| Q3 25 | 2.43× | 1.10× | ||
| Q2 25 | 3.93× | 2.41× | ||
| Q1 25 | 4.27× | 1.21× | ||
| Q4 24 | 10.47× | — | ||
| Q3 24 | 1.89× | 0.54× | ||
| Q2 24 | 2.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
